
Editorial: Trump's Opportunity Zones could help small businesses and struggling neighborhoods
There's plenty not to like about President Donald Trump's 'Big Beautiful Bill' now being hashed out in the Senate, not least of which is that it would enlarge the national debt. But at least one part of the budget bill stands to help the less fortunate, while still bringing smiles to the faces of the investor class.
Introduced in Trump's 2017 Tax Cuts and Jobs Act, Opportunity Zones offer generous tax incentives for private investors who put money into low-income communities across the country. The 2025 bill is shaping up to provide a revised, 2.0 version of O.Z.s, as they're known to their pals. And if the Senate gets its way, as seems likely, the bill not only will update and renew the program, but will also make it permanent.
The program is far from perfect, and the political left has complained that it's just another tax giveaway to the rich. But the program's flaws did not deter the city of Chicago and the state of Illinois from participating in it by identifying a slew of economically distressed communities ripe for O.Z. investment.
We suspect that Trump's local critics will grudgingly embrace a new O.Z. program if it becomes a permanent feature of the tax code. After all, other tools for combating disinvestment in poor communities haven't exactly worked wonders. This somewhat technical part of the 'BBB' could turn out to be a win for Chicago's South and West sides, as well as struggling suburbs and the deep-red rural areas.
O.Z.s were introduced after a bull market in real estate, stocks and bonds left many wealthy investors with profits to reinvest. Those investors were permitted to delay or eliminate paying taxes on capital gains by rolling their profits into needy parts of the country to develop real estate or build businesses.
Among the 50 states, more than 8,000 census tracts were eligible for the reinvested profits under the program. That included swaths of rural Illinois, as well as struggling spots such as Dolton. That's right, Pope Leo XIV's childhood home, is in a south suburb eligible for O.Z. investments.
Even many defenders conceded the program didn't fully work as planned. Most O.Z. money went into building new residential real estate, especially multi-family housing. That's good news, as it helps to address the nationwide shortage of affordable homes. But less funding than expected went into other types of real estate projects and still less into creating jobs at new or revived businesses.
Also, predictably, investors directed their funds into zones that were economically better off than others. It's obviously more prudent to put money into a development that serves a low-income population but also has resources and growth around it.
Still, who would gripe about a rundown part of an otherwise prosperous area getting a little help from private investors? As it turns out, plenty of people griped.
O.Z.s, their critics say, have failed to encourage investment in the most impoverished areas, and too much of the investment may well have happened anyway, without the tax incentive. In practice, the law has allowed windfall tax benefits for building pickleball courts and luxury condos as well as for low-income apartments.
Further, O.Z. investments have mostly failed to bring new, attractive jobs to the residents of poverty-stricken areas. And after the housing stock improves, gentrification sometimes pushes out residents the program was supposed to help.
You know that old saying about Democracy being the worst form of government except for all the others? O.Z.s are similar. They were never going to be a magic bullet for eliminating poverty, but they're better than many of the alternatives.
A research study published earlier this year found that O.Z. housing has cost taxpayers about $26,000 per unit, a fraction of the cost for government-built affordable housing. Remember, Mayor Brandon Johnson's Fifth City Commons project $884,000 per taxpayer-subsidized rental unit. And evidence shows the program has increased housing availability in places that need it, although not necessarily the ones that need it the most.
The push to renew O.Z.'s has an influential champion in Idaho Republican Sen. Mike Crapo, who chairs the Senate Finance Committee, and it strikes us as a ray of sunshine compared to so much else in the fiscally irresponsible GOP budget bill.
We'd like to see the 2.0 version of O.Z.s provide more incentives to help the poorest of the poor communities, and water down proposed rules that would overly favor rural America. But if O.Z.s can create housing in neglected areas that otherwise would get hardly any attention and do it at a lower cost to taxpayers than alternatives, bring 'em on.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

USA Today
9 minutes ago
- USA Today
Iran holds funeral for commanders and scientists killed in war with Israel
At least 16 scientists and 10 senior commanders were among those mourned at the funeral, according to Iran state media. June 28 (Reuters) - Large crowds of mourners dressed in black lined streets in Iran's capital Tehran as the country held a funeral on June 28 for top military commanders, nuclear scientists and some of the civilians killed during this month's aerial war with Israel. At least 16 scientists and 10 senior commanders were among those mourned at the funeral, according to state media, including armed forces chief Major General Mohammad Bagheri, Revolutionary Guards commander General Hossein Salami, and Guards Aerospace Force chief General Amir Ali Hajizadeh. Their coffins were driven into Tehran's Azadi Square adorned with their photos and national flags, as crowds waved flags and some reached out to touch the caskets and throw rose petals onto them. State-run Press TV showed an image of ballistic missiles on display. More: Few thought airstrikes could 'obliterate' Iran's nuclear program. Then Trump said they did. Mass prayers were later held in the square. State TV said the funeral, dubbed the "procession of the Martyrs of Power", was held for a total of 60 people killed in the war, including four women and four children. In attendance were President Masoud Pezeshkian and other senior figures including Ali Shamkhani, who was seriously wounded during the conflict and is an adviser to Iran's Supreme Leader Ayatollah Ali Khamenei, as well as Khamenei's son Mojtaba. "Today, Iranians, through heroic resistance against two regimes armed with nuclear weapons, protected their honour and dignity, and look to the future prouder, more dignified, and more resolute than ever," Foreign Minister Abbas Araqchi, who also attended the funeral, said in a Telegram post. More: The U.S. helped oust an Iranian regime before. Here's what happened in 1953. There was no immediate statement from Khamenei, who has not appeared publicly since the conflict began. In past funerals, he led prayers over the coffins of senior commanders ahead of public ceremonies broadcast on state television. Israel launched the air war on June 13, attacking Iranian nuclear facilities and killing top military commanders as well as civilians in the worst blow to the Islamic Republic since the 1980s war with Iraq. Iran retaliated with barrages of missiles on Israeli military sites, infrastructure and cities. The United States entered the war on June 22 with strikes on Iranian nuclear facilities. Trump threat Israel, the only Middle Eastern country widely believed to have nuclear weapons, said it aimed to prevent Tehran from developing its own nuclear weapons. Iran denies having a nuclear weapons program. The U.N. nuclear watchdog has said it has "no credible indication" of an active, coordinated weapons program in Iran. Bagheri, Salami and Hajizadeh were killed on June 13, the first day of the war. Bagheri was being buried at the Behesht Zahra cemetery outside Tehran mid-afternoon on June 28. Salami and Hajizadeh were due to be buried on June 29. President Donald Trump said on June 27 that he would consider bombing Iran again, while Khamenei, who has appeared in two pre-recorded video messages since the start of the war, has said Iran would respond to any future U.S. attack by striking U.S. military bases in the Middle East. A senior Israeli military official said on June 27 that Israel had delivered a "major blow" to Iran's nuclear project. On June 28, Iran's Revolutionary Guards said in a statement that Israel and the U.S. "failed to achieve their stated objectives" in the war. According to Iranian health ministry figures, 610 people were killed on the Iranian side in the war before a ceasefire went into effect on June 24. More than 4,700 were injured. Activist news agency HRANA put the number of killed at 974, including 387 civilians. Israel's health ministry said 28 were killed in Israel and 3,238 injured.


Boston Globe
13 minutes ago
- Boston Globe
New Englanders clash over Trump's sweeping health reforms
And he is not alone. In a recent Globe survey of 11 New Englanders across the political spectrum, all seven respondents who voted against Trump said they worry that basic health insurance and many vaccines will be harder to obtain for those who need them if the Big Beautiful Bill becomes law. The four respondents who voted for Trump, despite being unfamiliar with many of the legislation's specifics, said they support changes to health care programs to repair what some of them called a broken, bloated system. Advertisement The voters were surveyed as part of an ongoing Globe series on their views on the first year of the Trump administration, with previous installments centered on The cost of health care has been a major focus for Trump, who has said he wants to eliminate waste and fraud from programs such as Medicaid. The president has said he wants the legislation passed before July 4. But along with savings, Trantham noted, many experts predict that more Americans will end up uninsured if Trump's vision becomes the new landscape of national health care. Advertisement 'There will be more people who can't afford their medications. There'll be more people who avoid going to the doctor because they don't have the money,' said Trantham, who is an unenrolled voter and voted for former vice president Kamala Harris in 2024. 'And then they'll end up needing a higher level of medical care, which then puts a broad burden on the rest of us,' he added. Related : Trump's passed by the House, many The agency also predicted that 4 million people could see their access to food stamps reduced or eliminated. In addition to benefit cuts, the Congressional Budget Office estimated that the House bill would increase the US deficit by $2.4 trillion over the next decade. And on Thursday, Joann Flaminio, 69, a retired Democrat from Providence, said she is concerned that few people are aware of the myriad dangers tucked into the sprawling bill. 'The devil really is in the details. And one of the proposals in the Big Beautiful Bill — that requires Medicaid recipients to re-enroll every six months — is a draconian measure designed to deny services to those most in need,' said Flaminio, who served as retirement administrator for the state of Rhode Island. Advertisement 'My sister was on Medicaid in the final years of her life, and I know what the application process is like in order to get somebody approved. Many people hire a lawyer in order to do that, but it can be arduous, and it certainly is,' she added. The president's bill also would impose work requirements on Medicaid recipients, from ages 19 to 64, who would need to work at least 80 hours per month if they did not qualify for exemptions. From her experience, Flaminio said, linking benefits to work requirements is impractical. 'We tried to mandate work requirements ... for those people who are on disability benefits,' Flaminio said. 'And I would say, for the most part, it's a waste of time and effort. The vast majority of recipients, an estimated 96 percent, cannot work, which is the reason why they apply for Medicaid in the first place.' But for the survey's Trump supporters, trimming the Medicaid rolls is worthwhile if it rids the system of fraud and abuse. Seth Sole-Robertson, a 45-year-old Republican from Medway, was asked if Medicaid cuts concern him. 'I'd be concerned if I was an illegal alien,' Sole-Robertson answered, 'and I'd be concerned if I were committing fraud.' The goal is to strip benefits from 'people who are ineligible or taking it in two different states,' said Sole-Robertson, who owns a marine repair business. 'There's lots of hoopla or fake news about what's going on with Medicaid.' Karen Sysyn, 54, an unenrolled Trump supporter from Londonderry, N.H., said she wasn't sure where the bill was headed or what was in it. 'I hear a lot of rumors that they're looking at cutting Social Security and disability and stuff like that,' she said. Advertisement If people are able to work, taxpayers should not bear their burden, said Sysyn, who is searching for work after losing her job as a housing inspector. But if people are genuinely in need of support from Social Security or Medicare, they should receive support, she added. Another unenrolled Trump supporter, 56-year-old Brian Jankins of Sutton, was asked what he knew about the bill. 'Full disclosure, very little,' said Jankins, who works in banking. However, he added, 'our current health care system is broken and dysfunctional ... I'm not versed in what this bill does to address that, but it is broken.' Related : Respondents' opinions about Robert F. Kennedy Jr., the health and human services secretary, also were sharply divided, with Trump supporters endorsing his stance against vaccines, among other initiatives, and the president's opponents saying Kennedy was endangering lives. 'I think more Americans are going to die under some of the changes that he's making around vaccinations,' said Vanessa Coppola, a 42-year-old Democrat from North Yarmouth, Maine. Over the administration's first five months, Kennedy became a lightning rod for controversy because of his antivaccine stance, his references to autism as a preventable disease, and his ouster and replacement of the entire immunization advisory panel for the Centers for Disease Control and Prevention. Coppola, a job coach and consultant, is particularly worried about Kennedy's proposal to eliminate the COVID vaccine recommendation for healthy pregnant women. Those vaccinations provide coverage for newborns, who are particularly vulnerable to respiratory disease, she said. Anand Sharma, 53, a Democrat from Shrewsbury and electrical engineer, called the rolling drama at the Department of Health and Human Services part of 'the chaos [that] is everywhere right now.' Advertisement And Justina Perry, a 37-year-old Democrat from New Bedford, denounced Kennedy's antivaccine agenda. 'Viruses are going to love this,' said Perry, who runs a physical therapy clinic. 'They're going to be able to spread and spread, and they win in this situation because we're pulling back vaccine access. So the only one who should be excited about this is a virus.' But Darryll White, an unenrolled Trump voter from Skowhegan, Maine, supports Kennedy's efforts to change government guidance on vaccines. Kennedy's work is 'a long-haul scenario — to make America healthy again,' said White, 66, who added that efforts by the news media to 'demonize' the secretary have made his job harder. 'People have to understand that Robert Kennedy is under intense pressure,' added White, the director of a nonprofit community park. White said he supports Kennedy's proposal to upend the government's vaccine guidance. 'That's exactly what needs to happen,' said White, who believed the government was not transparent during the pandemic about possible adverse effects of the COVID vaccine. The respondents were sharply divided yet again about the administration's drastic cuts in medical research grants, and those views aligned with whether they had voted for the president. The cuts have had an outsize effect on universities and other research institutions in the Boston area, particularly at Harvard University, where the government has canceled about $2.6 billion in awarded grants. 'He's cutting off his nose to spite his face,' Rosemary Shea, 62, an unenrolled voter from Hampton, N.H., said of Trump, who she voted against. 'I mean, Harvard is not just doing this research for themselves. They're doing it for the world.' Advertisement 'These universities are doing great research for diseases that are still out there that we have not cracked yet — Parkinson's, cancer, all different types of cancers," Shea added. 'He's just decided 'nope.' And I haven't even heard a logical explanation for it.' Sole-Robertson, the Medway Republican, offered a sharply different take on the government's role in funding medical research. 'A lot of this needs to be shifted back to private industry and raising funds in the private sector,' he said. 'I think a lot of it is just pure nonsense.' Brian MacQuarrie can be reached at


American Press
15 minutes ago
- American Press
Jim Beam column:CVS lawsuits won't solve PBM concerns
CVS has been targeted by three lalwsuits filed by the Louisiana attorney general for irs questionable practices.(Photo courtesy of Louisiana legislators and the state's citizens got acquainted near the end of this year's fiscal session with organizations we have heard little about — pharmacy benefit managers (PBMs). Large employers and health insurance companies pay PBMs to act as middlemen to negotiate drug prices. House Bill 358 by Rep. Dustin Miller, D-Opelousas, was one of three measures filed dealing with PBMs. A conference committee changed the bill and it ended up saying that no permit to operate a pharmacy can be granted or renewed to a pharmacy that is wholly or partially owned or controlled by a pharmacy benefit manager. Miller's bill passed the House 95-0 and the Senate 37-0. However, the House rejected changes made by the Senate and a conference committee was eventually appointed to iron out the differences between the two chambers. The PBM change that was inserted into the bill by the conference committee was accepted by the House but the legislation died in the Senate. Senate President Cameron Henry, R-Metairie, later explained that there was no testimony on that complicated change in the bill. Donald Trump Jr., a friend of Louisiana Gov. Jeff Landry, said that bill should pass the Legislature. Landry got so upset when it didn't, he is still threatening to call a special session to pass it. If a Trump says do it, Landry always goes to war in order to get it done. The Advocate reported that Amy Thibault, a spokesperson for CVS, which owns both a PBM and a nationwide chain of drug stores, said the bill would have forced it to close its 119 stores in Louisiana. She said it would affect about 1 million patients across the state and 22,000 patients who receive high-cost specialty drugs that smaller pharmacies find difficult to handle. An anti-PBM bill did pass. Rep. Michael Echols, R-Monroe, sponsored HB 264 that passed both houses unanimously. The newspaper said it favored independent pharmacies by prohibiting PBMs from steering customers to pharmacies they own and by mandating that discounts negotiated by PBMs go to employers and consumers. Echols' bill has been sent to Gov. Landry, but he hasn't signed it or vetoed it yet. However, we know he's still upset because The Advocate reported that the state has filed three lawsuits against CVS accusing it of 'unethical and deceptive acts' in its use of customer data for political lobbying. All three cases allege that CVS violated Louisiana's Unfair Trade Practices and Consumer Protection Law. One lawsuit says the text messages CVS sent to its customers were 'inaccurate, misleading and deceptive.' And that they were intended to incite fear among vulnerable people. The second suit alleges the company has used its size and control of insurers, PBMs and drugstores to squeeze out competition and drive up drug costs. The third lawsuit accuses CVS of abusing its market power to 'inflict economic harm' and impose unfair fees on independent pharmacies 'under threat of being expelled from the CVS network.' The Center Square said CVS Health is pushing back against claims that the company engaged in deceptive, anticompetitive practices. In a statement, CVS called the lawsuits 'without merit' and pledged to defend itself vigorously. CVS said, 'Our communication with CVS customers, patients and members of the community was consistent with the law.' Rather than filing lawsuits, state Sen. Kirk Tallbot, R-River Ridge, had a better solution. When the Senate refused to approve Miller's bill he sponsored Senate Resolution 209. The resolution requests the Louisiana Department of Health to study the impacts of prohibiting pharmacy benefit manager ownership of pharmacies in Louisiana and to submit a report to the Legislature. I found a helpful explanation about PBMs at in a story that said they were created to negotiate better deals for consumers on medicines. However, it said instead PBMs 'have sometimes driven up the cost of prescriptions — while also putting the survival of community pharmacies at risk.' So, it's possible that Landry and legislators should do something to prevent that from happening, However, rushing to judgment with lawsuits seldom solves major problems. More information on PBMs would better serve the legislators who pass this state's laws and the people who are served by the state's drugstores. Henry said Miller's bill wouldn't have taken effect until 2027. Instead of lawsuits, PBMs can be debated during the 2026 legislative session to give legislators the background they need on PBMs. Jim Beam, the retired editor of the American Press, has covered people and politics for more than six decades. Contact him at 337-515-8871 or Reply Forward Add reaction